Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Blood levels of alpha-1-antichymotrypsin and risk factors for Alzheimer's disease: effects of gender and apolipoprotein E genotype.

Dementia and geriatric cognitive disorders - 1 Jan 2000

Licastro F, Masliah E, Pedrini S, Thal L J

Abstract excerpt

Concentrations of alpha(1)-antichymotrypsin (ACT) were measured in serum or plasma samples from 137 patients with late-onset probable Alzheimer's disease (AD) and 89 controls. Levels of ACT from sera or plasma from both AD or controls were different, being highest in serum samples. Increased levels of serum or plasma ACT and normal levels of C-reactive protein (CRP) were found in AD. Differences in serum ACT...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to alpha 1-Antichymotrypsin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Alzheimer Disease

Share to Apolipoproteins E

Share to CRP gene

Share to Genotype

Share to Mental Status Schedule

Share to Reference Values

Source

Identifiers

PMID: 10629358
DOI: 10.1159/000017209

Genes

APOE
CRP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Blood levels of alpha-1-antichymotrypsin and risk factors for Alzheimer's disease: effects of gender and apolipoprotein E genotype.PMID 10629358Read ↗

Plasma and cerebrospinal fluid alpha1-antichymotrypsin levels in Alzheimer's disease: correlation with cognitive impairment.Semantic proximity Read ↗

Plasma alpha1-antichymotrypsin in Alzheimer's disease; relationships with APOE genotypes.Semantic proximity Read ↗

Gene polymorphism affecting alpha1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk.Semantic proximity Read ↗

Apolipoprotein E and alpha-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease.Semantic proximity Read ↗

Alpha1-antichymotrypsin polymorphism in Japanese cases of Alzheimer's disease.Semantic proximity Read ↗

Distribution of plasma alpha 1-antichymotrypsin levels in Alzheimer disease patients and controls and their genetic controls.Semantic proximity Read ↗

No association between alpha-1-antichymotrypsin polymorphism and Alzheimer's disease in Chinese.Semantic proximity Read ↗

A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease.Semantic proximity Read ↗

No association between the alpha 1-antichymotrypsin A allele and Alzheimer's disease.Semantic proximity Read ↗

Polygenic determinants of Alzheimer's disease: modulation of the risk by alpha-1-antichymotrypsin.Semantic proximity Read ↗

Alpha-1-antichymotrypsin gene polymorphism and risk for sporadic Alzheimer's disease in a German population.Semantic proximity Read ↗

APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.